Understanding atopic dermatitis: the importance of clinically effective management strategies
This article aims to provide a comprehensive overview of atopic dermatitis (AD) management, highlighting the importance of early intervention and continued preventative measures. By Caitlin Hardman BPharm, GradCertHPE, FANZCAP (Education …
Psychedelic science
Psychedelics are known to elicit altered states of consciousness, but can they provide therapeutic benefit? By Dr Martin Williams, Executive Director of Psychedelic Research and Science and Medicine (Prism Limited), …
Chronic spontaneous urticaria: an overview
Pharmacists may be the first contact point for patients experiencing symptoms of chronic spontaneous urticaria. This article aims to provide an overview of the condition and management options, with a …
Butler to launch vision for pharmacy
Minister for Health and Aged Care, Mark Butler, will unveil a plan for the evolution of the pharmacy profession for the next six years The Pharmaceutical Society of Australia’s (PSA’s) …
‘We’re a third-world country in terms of drug access’
Health professionals’ ability to initiate women on HRT is being limited by medicines shortages, Senate committee told Prescribers are being left with difficult choices when it comes to starting hormone …
APC drops KAPS for new assessment
Overseas trained pharmacists to sit new skills competency assessment from March 2025 Australia’s Knowledge Assessment of Pharmaceutical Sciences (KAPS) exams will be dropped at the end of the year in …
NSW pharmacist update
Information from the Pharmaceutical Services Unit (PSU) The PDL Professional Officers often receive enquiries relating to the validity of psychostimulant prescriptions written for NSW patients. The Pharmaceutical Services …
‘This is like a land mine.’
Complaints over DAAs, missing S8s and owing scripts shared by proprietor and NSW Pharmacy Council member in reminding owners of their responsibilities Owners are ultimately responsible for everything that happens …
New therapy on the way
A new Pharmacist-Only smoking cessation medicine is soon to be available A smoking cessation medicine newly available and approved in Australia has been listed as a Schedule 3 (Pharmacist-Only) medicine. …
Turning over a new page
Pharmacist Dr Amy Page named inaugural director of new medicines research centre Two leading pharmacists are at the helm of the newly launched Centre for Optimisation of Medicines, School of …
Research roundup
Debbie Rigby rounds up the latest in research news An update on oral antiplatelet drug interactions with proton pump inhibitors: what are the risks? Aspirin and anti-P2Y12 are widely prescribed …
